Expression of key hypoxia sensing prolyl‐hydroxylases PHD1, ‐2 and ‐3 in pancreaticobiliary cancer
Lucy Gossage(Nottingham University Hospitals NHS Trust), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Helen Turley(John Radcliffe Hospital), Mark M. Aloysius(University of Nottingham), Adrian L. Harris(University of Oxford), Dileep N. Lobo(Nottingham University Hospitals NHS Trust), Khaleel Fareed(University of Nottingham), Abed M. Zaitoun(GlaxoSmithKline (United Kingdom))
Cited by 40
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k